Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Ophthalmology. Retina
|
June 4, 2026
Gildeuretinol Acetate vs Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The SAGA Randomized Clinical Trial
David S Boyer, Leonide Saad, Ilyas Washington, et al.
Ophthalmology Science
|
April 28, 2025
Longitudinal Imaging of the Parafoveal Cone Mosaic in Congenital Achromatopsia
Nickolas Chen, Katie M Litts, Danica Nikezic, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 14, 2020
Current Clinical Applications of In Vivo Gene Therapy with AAVs
Jerry R Mendell, Samiah A Al-Zaidy, Louise R Rodino-Klapac, et al.
Current Eye Research
|
February 29, 2020
Interocular Symmetry of Foveal Cone Topography in Congenital Achromatopsia
Katie M Litts, Michalis Georgiou, Christopher S Langlo, et al.
Plos One
|
May 3, 2013
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
Christine N Kay, Renee C Ryals, George V Aslanidi, et al.
Investigative Ophthalmology & Visual Science
|
May 5, 2016
Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome
Lynn W Sun, Ryan D Johnson, Christopher S Langlo, et al.
Human Gene Therapy
|
December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis
Sanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.
Iscience
|
October 24, 2022
Night vision restored in days after decades of congenital blindness
Samuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.
Human Mutation
|
March 10, 2022
Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study
Robert B Hufnagel, Wendi Liang, Jacque L Duncan, et al.
Lancet (London, England)
|
September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study
Paul Yang, Laura P Pardon, Allen C Ho, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Ophthalmology. Retina
|
June 4, 2026
Gildeuretinol Acetate vs Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The SAGA Randomized Clinical Trial
David S Boyer, Leonide Saad, Ilyas Washington, et al.
Ophthalmology Science
|
April 28, 2025
Longitudinal Imaging of the Parafoveal Cone Mosaic in Congenital Achromatopsia
Nickolas Chen, Katie M Litts, Danica Nikezic, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 14, 2020
Current Clinical Applications of In Vivo Gene Therapy with AAVs
Jerry R Mendell, Samiah A Al-Zaidy, Louise R Rodino-Klapac, et al.
Current Eye Research
|
February 29, 2020
Interocular Symmetry of Foveal Cone Topography in Congenital Achromatopsia
Katie M Litts, Michalis Georgiou, Christopher S Langlo, et al.
Plos One
|
May 3, 2013
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
Christine N Kay, Renee C Ryals, George V Aslanidi, et al.
Investigative Ophthalmology & Visual Science
|
May 5, 2016
Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome
Lynn W Sun, Ryan D Johnson, Christopher S Langlo, et al.
Human Gene Therapy
|
December 6, 2012
AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis
Sanford L Boye, Igor V Peshenko, Wei Chieh Huang, et al.
Iscience
|
October 24, 2022
Night vision restored in days after decades of congenital blindness
Samuel G Jacobson, Artur V Cideciyan, Allen C Ho, et al.
Human Mutation
|
March 10, 2022
Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study
Robert B Hufnagel, Wendi Liang, Jacque L Duncan, et al.
Lancet (London, England)
|
September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study
Paul Yang, Laura P Pardon, Allen C Ho, et al.
Page
of 4